A Curated Audience of Analytical Development Decision-Makers, Scientists & Innovators
There’s already a real buzz building around the 8th Cell & Gene Therapy Analytical Development Summit, with so many teams particularly excited about having the cell and gene therapy communities together in one room.
People are looking forward to seeing what others are working on, getting feedback on their own approaches, and having more focused conversations around the analytical challenges they’re facing, with the poster session, workshops, and dedicated networking creating plenty of opportunities to do just that.
Aurion Biotech are sending 8, Voyager are sending 3,…see who else is already in the room
Participation trends
- 50% of participating biopharma organizations are bringing multiple Analytical Development and QC team members
- A seniority-rich audience, with 60% of confirmed attendees at Director level or above
- 78% of attendees represent leading biopharma companies
Audience Breakdown
Take a sneak preview at the 100+ senior and technical stakeholders joining us for the 8th Cell & Gene Therapy Analytical Development Summit.
Explore the Full Event Guide
- Interactive Workshops on Flow Cytometry, NGS & Potency Assay Development Challenges
- Exclusive Case Studies on Potency, Comparability & Analytical Control Across Cell & Gene Therapy
- Expert-Led Discussions on AI, Single-Cell Analytics & Next-Generation Analytical Technologies
- Practical Strategies for Method Transfer, QC Readiness & Commercialization Success
- Unrivaled Networking with Analytical Development, QC, CMC & Regulatory Leaders from Across the Industry
